Alzheimer’s Patients

Typically, Alzheimer’s disease begins in people over 65 years of age, although 4–5% of cases are early-onset Alzheimer’s. The underlying mechanisms of the disease are thought to be similar in both early and late onset forms. The disease affects about 10% of people 65 years and older and 65% of them are women.

A disease-modifying treatment should start early

There are three stages associated with Alzheimer’s disease: Mild Cognitive Impairment (MCI) due to Alzheimer’s disease, mild to moderate Alzheimer’s and severe Alzheimer’s disease. It is, however, very difficult to fully separate these stages. Sometimes they are also referred as early, middle and late; or mild, moderate and severe, Alzheimer’s.

Alzheimer’s disease starts several years before the individual exhibits any clinical symptoms. The disease also develops progressively, which means that the symptoms increase as the disease progresses into full dementia. A disease-modifying treatment should preferably be started as early as possible, before the deterioration of the brain has progressed too far (Alzheimers Association).

Learn more

Find out more about the societal impact of Alzheimer’s disease and the global unmet medical need.